Charts GlucoTrack

Stocks

Market Closed - Nasdaq 00:00:00 29/08/2026 +04			5-day change	1st Jan Change
0.2820 ^USD	-1.47%		-18.83%	-92.71%

08-25	Lokahi Therapeutics Inc., a subsidiary of Glucotrack, Inc. Initiates Clinical Trial Manufacturing For LT-100	CI
08-19	Glucotrack, Inc. Approves the Election of Erik Emerson and Paul V. Goode to the Board of Directors	CI

Stock exchange

Nasdaq GCTK 0.2820 $ -1.47% 756K $

Markets		Price	Change	Volumes
Nasdaq	GCTK	0.2820USD	-1.47%	756K $
CBOE	GCTK	0.2825USD	-4.04%	3.16K $

ProRealTime Chart